drugset / Trial / NCT01797913

The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer

NCT01797913 ↗

Phase 2 Completed 70 enrolled Fudan University
NaSingle-groupOpen-labelTreatment

Summary

assess the efficacy and safety of gemcitabine in the maintenance treatment of advanced non-small cell lung cancer

Timeline

Start
2008-08
Primary completion
2015-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 1000 mg/m2 Intravenous

Indications

No indication recorded.